Insights into 3D Structure of ADAMTS13: A Stepping Stone towards Novel Therapeutic Treatment of Thrombotic Thrombocytopenic Purpura (original) (raw)

Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents murine models of thrombotic thrombocytopenic purpura

Long Zheng

Blood, 2015

View PDFchevron_right

Deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Editorial

HAN-MOU TSAI

Arteriosclerosis Thrombosis and Vascular Biology, 2003

View PDFchevron_right

Deficiency of ADAMTS13 Causes Thrombotic Thrombocytopenic Purpura

HAN-MOU TSAI

2010

View PDFchevron_right

Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura

Toshiyuki Miyata

Blood, 2006

View PDFchevron_right

Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura

Long Zheng

Blood, 2012

View PDFchevron_right

Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

Bernhard Lämmle

Hematology-American Society Hematology Education Program, 2012

View PDFchevron_right

Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura

Mohammad Abdelgawwad

Arteriosclerosis, Thrombosis, and Vascular Biology

View PDFchevron_right

Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Bernhard Lämmle

Blood, 2004

View PDFchevron_right

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura

Hans Deckmyn, M. Maeyer

Blood, 2009

View PDFchevron_right

Carboxyl Terminus of ADAMTS13 Directly Inhibits Platelet Aggregation and Ultra Large von Willebrand Factor String Formation Under Flow in a Free-Thiol–Dependent Manner

Long Zheng

Arteriosclerosis, Thrombosis, and Vascular Biology, 2013

View PDFchevron_right

ADAMTS13 and von Willebrand factor interactions

Long Zheng

Current Opinion in Hematology, 2015

View PDFchevron_right

Von Willebrand Factor, ADAMTS-13, and Thrombotic Thrombocytopenic Purpura

Trung Nguyen

Seminars in Thrombosis and Hemostasis, 2010

View PDFchevron_right

The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice

hans deckmyn

Journal of thrombosis and haemostasis : JTH, 2014

View PDFchevron_right

Degradation of Platelet-von Willebrand Factor Complexes by Plasmin: An Alternative/Backup Mechanism to ADAMTS13

Anil Chauhan

Circulation, 2014

View PDFchevron_right

The function of ADAMTS13 in thrombogenesis in vivo: insights from mutant mice

Anil Chauhan

International Journal of Hematology, 2010

View PDFchevron_right

Enzymatically Active ADAMTS13 Variants Are Not Inhibited by Anti-ADAMTS13 Autoantibodies

HAN-MOU TSAI

Journal of Biological Chemistry, 2005

View PDFchevron_right

ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura

HAN-MOU TSAI

European Journal of Pediatrics, 2006

View PDFchevron_right

ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model

Long Zheng

Transfusion, 2016

View PDFchevron_right

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura

Andres Männik

Haematologica

View PDFchevron_right

Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura

Lawrence Rice

Journal of Thrombosis and Haemostasis, 2006

View PDFchevron_right

Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo

Long Zheng

Journal of Thrombosis and Haemostasis, 2006

View PDFchevron_right

The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation

Anil Chauhan

Blood, 2009

View PDFchevron_right

Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity

Gerry Nicolaes

Journal of Biological Chemistry, 2021

View PDFchevron_right

Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura

hans deckmyn

PLOS ONE, 2016

View PDFchevron_right

Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura

Valentina Bianchi

Blood, 2002

View PDFchevron_right

Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura

Bernhard Lämmle

Blood Advances, 2021

View PDFchevron_right

Thrombospondin1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro

YIMING ZHAO

Thrombosis Research, 2010

View PDFchevron_right

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

Ravindra Sarode

Nature, 2001

View PDFchevron_right